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OBJECTIVE: The objective of this selective evidence-based medicine (EBM) review is to 
determine whether or not “Is an endoscopic thoracic sympathectomy (ETS) at the T2 level 
effective in resolving palmar hyperhidrosis and resulting in patient satisfaction?” 
 
STUDY DESIGN: Systematic review of three randomized control trials published in 2009, 
2016, and 2017, all in the English language. Studies were analyzed and reviewed based on 
population, intervention, and outcomes measured. 
 
DATA SOURCES: Three randomized controlled trials where all published in peer-reviewed 
journals and researched using the PubMed and CINAHL databases. 
 
OUTCOMES MEASURED:  All three studies measured the presence or absence of palmar 
hyperhidrosis (PH) and/or compensatory hyperhidrosis (CH) via patient report and physical 
examination. All studies also measured patient satisfaction through patient questionnaires. 
 
RESULTS: All patients in the studies except one showed immediate anhidrosis postoperatively 
and no PH recurrence. Despite great initial postoperative results, many patients developed CH 
symptoms. Patient satisfaction rate was high in all three articles reviewed. 
 
CONCLUSIONS: The results from this systemic review suggest an endoscopic thoracic 
sympathectomy (ETS) at the T2 level is adequately effective in resolving palmar hyperhidrosis 
and resulting in patient satisfaction. 
 
KEY WORDS: Sympathectomy, Hyperhidrosis, Randomized Control Trial 
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INTRODUCTION 
Palmar hyperhidrosis (PH) is an excessive, uncontrollable, sweating of the hands. PH 
occurs equally in both genders and can be present at any age, but tends to affect adolescents and 
young adults most often due to the increased activation of eccrine sweat glands during puberty.1,2 
In the US, 15.3 million individuals are estimated to be living with hyperhidrosis on varying 
bilateral cutaneous body regions, with 0.3-4.5% of the general population having the condition 
confined to just their palms.2,3 There is increasing evidence for a genetic component to the 
condition since most patients present with a family history.1 The sweating is thought to be caused 
by a benign, idiopathic hyperfunctioning of the sympathetic nervous system in thermoregulation 
of the body in response to normal heat or exercise.1 The excessive diaphoresis can seriously 
disrupt a person’s daily professional, emotional, and social lives potentially leading to lost 
opportunities and problems of a psychosocial nature.4 
Many patients learn to live with their condition despite the effect it has on their quality of 
life as they do not realize it is treatable. The small group that do seek treatment usually do so 
through a dermatologist who may initially suggest a number of creams, lotions, or antiperspirants 
for the patient.5 Patents can also receive Botox injections, microwave therapy, or an endoscopic 
thoracic sympathectomy (ETS).4 The total healthcare cost of PH has not been identified since 
treatments and their expense vary greatly. Certain over the counter options can cost $8-20, 
whereas more aggressive treatments, such as surgery, can cost up to $20,000.3 Additional 
expenses include frequent new clothing, dry cleaning, and other specific absorbent pads, towels, 
or fabrics for daily disease management. Many conservative treatments for palmer hyperhidrosis 
are found to be unsuccessful and unsatisfactory, leading some patients to instead opt for the more 
definitive solution of surgery.2 Currently, the ETS is the most effective and definitive therapeutic 
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approach to the treatment of PH.1 The specific neural ganglion level of the ETS performed is still 
debated by the medical community.6 
OBJECTIVE 
The objective of this selective EBM review is to determine whether or not “Is an endoscopic 
thoracic sympathectomy (ETS) at the T2 level effective in resolving palmar hyperhidrosis and 
resulting in patient satisfaction?” 
METHODS 
In this selective evidence-based medicine (EBM) review, three randomized control 
studies were analyzed and reviewed based on population, intervention, and outcomes measured. 
The population includes adults or young adults with palmar hyperhidrosis. Experimental 
intervention reviewed was an ETS at T2 and compared to ETS at other levels (T31,2, T2-T36). All 
patients that participated in the study were blind as to which ganglion level their EST surgery 
was being performed at. The degree of patient satisfaction with relation to resolution, 
reoccurrence, incidence, or severity of PH or compensatory hyperhidrosis (CH) were the 
measured outcomes.  
The three articles studied were published in peer reviewed journals, selected using the 
research databases of PubMed or CINAHL, all written in English, and dated from 2009-2017. 
Keywords used in the searches included “hyperhidrosis,” “sympathectomy,” and “randomized 
control trial.” Articles where chosen based on their relevance and inclusion of patient-oriented 
outcomes (POEMS). Other inclusion criteria were full text RCT studies done on humans 
published after the year 2008. Exclusion criteria included systematic reviews published before 
2008 and any animal studies. These three studies reported statistics as NNT, EER, CER, RBI, 
ABI, and/or p values. Characteristics of each study are outlined in Table 1.   
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Table 1. Demographics & Characteristics of Included Studies  
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OUTCOMES MEASURED 
 The primary outcome measured in all three studies was the presence or absence of PH 
and/or compensatory hyperhidrosis (CH) via patient report and physical examination of patients 
who were originally diagnosed with PH. All studies also measured patient satisfaction through 
questionnaires, though questionnaires varied between the studies.  
RESULTS 
 All three randomized control studies compared two groups that underwent ETS and 
resulted in no mortality.1,2,6 Two studies had one group receive bilateral ETS at ganglion level of 
T2, while the other group’s ETS were completed at the T3 level.1,2 In the third study all patients 
undergoing ETS received a T2 level ablation on one side of the body and a combined T2-T3 
level ablation on the other side, with the two groups differing in which side of the body was used 
for each ETS ganglion level type.6 Patients were selected randomly for their group of treatment 
and all blind to the ETS level preformed in all studies. Demographics, inclusion criteria, and 
exclusion criteria for all the studies can be seen in Table 1.  
In the Yazbek et al.1 study each group equally consisted of 30 patients. Patients had five 
clinical assessments through the study to assess for palmar anhidrosis, CH, and patient degree of 
satisfaction using the quality-of-life protocol classifying satisfaction into five levels.1 Three 
patients (5%) were lost from the study during follow up and not included in later assessments.1 
The baseline assessment, in the immediate postoperative period, found all patients reported 
anhidrosis.1 Only one patient in the T3 group denied anhidrosis at the next assessment 1 week 
after surgery; they had a second negative outcome following a repeat surgery and was deemed a 
case of “therapeutic failure.”1 At the subsequent three return assessments at one month, six 
months, and between 12-34 (mean of 20) months post-surgery all other patients continued to 
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have no PH recurrence.1 This study resulted in varying severity of CH for all patients of both 
groups by the final assessment postoperatively as seen in Table 2. Association between ETS 
level and surgery results or complications were investigated using the chi-square of Fisher exact 
test.1 The patient who experienced a “therapeutic failure,” was not included in the last two 
assessments for CH due to the timeline coinciding with their repeat surgery.1 The two compared 
procedures at T2 or T3 were not statistically significant for either producing a lessor rate of CH 
presence compared to each other, but the T3 procedure was statistically significant in resulting in 
a non-severe form of CH instead of severe CH compared to the T2 procedure at all three later 
postoperative.1  The quality-of-life protocol measured patient satisfaction by classifying a 
summed total score of the questionnaire completed by patients into five levels based on 
“situations in daily life in which hyperhidrosis might interfere,” seen in Table 3.1 On average, in 
both groups, all patients’ quality-of-life was considered very poor preoperatively, then improved 
to excellent in all those still able to be assessed postoperatively. There was no statistically 
significant improvement in quality of life and therefore patient satisfaction with the procedure 
done at T2 as compared to T3.1  
Table 2.  CH Presence and Severity After ETS as Measured by Yazbek et at.1 2009 
 1 month  6 months  20 months  
 T2:T3 p value T2:T3 p value T2:T3 p value 






With CH total 26:27 30:29 28:29 






Severe CH 10:0 10:3 13:4 
NA: couldn’t evaluate; CH compensatory hyperhidrosis; p-value <0.05 statistically significant 
 
Table 3.  Patient Satisfaction Total Scores of Quality-of-Life Protocol by Yazbek et at.1 
2009 
 T2 T3 p value 
1 week preop (median) 92 (67-100) Very Poor 87.5 (75-100) Very Poor 0.3052 
1 month postop (median) 23 (20-47) Excellent 23 (20-42) Excellent 0.8423 
6 month postop (median) 24 (20-56) Excellent 24 (19-52) Excellent 0.3905 
20 month postop (median) 26 (20-52) Excellent 29 (21-43) Excellent 0.7609 
Total score range of 20-100; Score >84 as Very Poor, 69-84 as Poor, 52-68 as Good, 36-51 as Very Good, and 20-
35 as Excellent; p-value <0.05 statistically significant 
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In the Turkyilmaz et al.2 study, each group equally consisted of 25 patients. All patients 
in both groups presented with palmar anhidrosis immediately after surgery.2 All subjects were 
interviewed, assessed, and physically examined for PH recurrence, CH, and patient satisfaction 
postoperatively at 1 month and 10-16 months (median 13) with no loss to follow up.2 No 
recurrence of PH occurred to any subjects during this study, nor any CH within the first month.2 
At one year follow up, three patients in the group T2 ETS and two from the T3 ETS group 
exhibited signs of CH on the back or abdomen, though only one subject from group T2 found 
their symptoms to be severe leading to dissatisfaction of the procedure performed.2 Overall both 
groups experienced high patient satisfaction rates throughout the study with their specific scoring 
found in Table 4. Using the chi-square test comparisons, neither CH or patient satisfaction rates 
were found to be statistically significant between the two ETS ablation level groups (p values: 
0.637 and 0.203 respectively; p-value <0.05 statistically significant).2  
Table 4. Patient Satisfaction Scoring by Turkyilmaz et al.2 2017 






1 month T2 (n=25) 25 (100%) 0 0 100% 0 
 T3 (n=25)  25 (100%) 0 0 100%  0 
Median 13 
months 
T2 (n=25) 22 (88%) 2 (8%) 1 (4%) 96% 4% 
 T3 (n=25)  23 (92%) 2 (8%) 0 100% 0 
 
 In the long-term Ong et al.6 study 25 of the 39 patients had their combined T2-T3 ETS on 
the right side and the single T2 ETS on their left side of the body. The other 14 patients had the 
same procedures preformed on opposite sides. Immediately after surgery, all 39 patients 
exhibited anhidrosis of the palms bilaterally.6 Twelve patients (43.6%) were lost in the years 
following  procedure.6 An observer, who was also blind to the ganglion level of each patient’s 
procedure, assessed all the remaining patients via telephone interview for any PH recurrence, 
CH, and patient satisfaction.6 To compare T2 single level verse T2–T3 multi-level ablation, “the 
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level of sympathectomy on one side was matched to the ipsilateral recurrence of palmar 
hyperhidrosis, the site and the severity of compensatory sweating for body parts that were not 
found in the midline (axilla and lower limbs specifically).”6 This study followed the International 
Hyperhidrosis Society’s disease severity scale but used a grade system instead of points.6 Four of 
the 22 patients successfully contacted later in the study had developed a recurrence of PH 
bilaterally, though it was milder than their preoperative symptoms.6 Twenty patients experienced 
some bilateral CH in varying forms and found the most common site of CH to be the trunk.6 For 
patients experiencing PH and/or CH there was, “no absolute difference in the severity of 
sweating,” between the two ETS group levels.6 Overall, 16 of the 22 final study participants were 
satisfied with their ETS results.6 Those that were not satisfied in the Ong et al.6 study reported it 
being due to forms of PH recurrence in 2 patients or CH in 4 patients. Similarly, patient 
satisfaction was also not found to be significantly higher in one ETS group than the other. All 
results for Ong et al.6 found in Table 5.  
Table 5.  Long-term Clinical Outcomes of Both ETS Groups Measured by Ong et al.6 2016 
Outcomes Scale Results (n=22) Totals (n=22) 
PH 
Recurrence 
No 18 (81.8%) No 18 (81.8%) 
Yes (mild) 2 (9.1%) 
Yes 4 (18.2%) Yes (moderate) 0 
Yes (severe) 2 (9.1%) 
CH 
No 2 (9.1%) No 2 (9.1%) 
Yes 20 (90.9%) Yes 20 (90.9%) 
Patient 
Satisfaction 
Very Satisfied 13 (59.2%) 
Satisfied  16 (72.8%) 
Satisfied 3 (13.6%) 
Dissatisfied 3 (13.6%) 
Dissatisfied 6 (27.2%) 
Very Dissatisfied 3 (13.6%) 
 
Comparisons of all three studies can be seen in Tables 6 and 7.  All but one patient in the 
three studies experienced immediate postoperative anhidrosis.1,2,6 Specifically, for those with the 
T2 level ETS, the surgery was 100% successful in achieving instant anhidrosis. Out of three, a 
single study had recurrence and did involve ETS at T2 at a rate of 22%, which was only slightly 
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higher than the typical report average of 18%.6 Despite great initial postoperative results, in each 
study many patients developed varied CH symptoms across the board with different ranges in 
comparison to the usual average of 60%.6 No specific ETS level reviewed was able to 
completely avoid the CH effect.  Patient satisfaction rate in general and specifically for T2 ETS 
was high in all three articles reviewed.1,2,6   
Table 6.  Treatment Effects on Patient Satisfaction of Included Studies 
Study Yazbek et al.1 Turkyilmaz et al.2 Ong et al.6 
CER 0.9655 1.0 
No data due to study data 
being presented as 
combined not compared 
EER 1.0 0.92 
RBI 0.0357 0.0417 
ABI 0.0345 -0.04 
NNT -29 -25 
Treatment effect p-value 0.7609 0.203 No comment 
p-value <0.05 statistically significant 
 





Yazbek et al.1 Turkyilmaz et al.2 Ong et al.6 
  Full T2 Full T2 Full T2 
Initial 
Anhidrosis  
 59/60=98% 30/30=100% 50/50=100% 25/25=100% 39/39=100% 
All 
subjects 











18%6 0/59=0% 0/30=0% 0/50=0% 0/25=0% 4/18=22% 
Final CH 
Values 
60%6 57/57=100% 28/28=100% 5/50=20% 3/25=12% 20/22=91% 















As stated previously, conservative treatments for PH usually produces unsatisfactory 
results. In the past however, that was all patients were offered. Today a multitude of conservative 
and more invasive options are offered, with the most definitive treatment being the ETS.1 This 
permeant surgical procedure, preformed under anesthesia and lasting less than one hour, attempts 
to block signals from the sympathetic nerve trunk to sweat glands by destroying their neural 
pathways through cauterization or ablation.3,6 This procedure can be confirmed in the operating 
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room by an increased temperature reading on a finger prob.6 To do this a lung may be 
temporarily collapsed for access to the nerve pathways in question. At the end of surgery any 
residing air is evacuated from the pleural space and postoperatively patients undergo routine 
“chest radiography to exclude pulmonary or pleural abnormalities.”2 Thoracic sympathectomies 
had high morbidity rates in the past, that were improved as videothoracoscopy was developed.1. 
Today videothoracopscopic sympathectomy is considered the “surgical technique of choice,” due 
to success rates, increased safety, further development of the technique, more experienced 
surgical teams, minimized invasiveness, and the esthetically pleasing result.1,2,6  Standardizing as 
much of the procedure process is important to help prevent adverse outcomes.2  
 If the ETS does not immediately improve the PH it is usually due to sympathetic level 
incomplete ablation or mistaken anatomic structure cauterization and therefore an “inadequate 
sympathectomy,” which can lead to more postoperative complications.1,6 With a failed result, 
most providers encourage a repeat procedure, which will usually receive the desired anhidrosis 
result.1,6 Pleural adhesions from the first surgery can make a subsequent procedure difficult and 
leading to possible “anatomic variations” in the surgeons technique.6 If there is still no 
improvement, as seen in the Yazvek et al.1 study patient, the subject may have experienced a rare 
phenomenon called the “neuroloigic escape route,” where the body’s sympathetic signals to the 
sweat glands evade blockage.1 Common complications of ETS include, but are not limited to, PH 
recurrence, CH, overly dryness to previously hyperhidrosis effected areas, Horner’s syndrome, 
pneumothorax, subcutaneous emphysema, and/or prolonged hospital stays. All of these potential 
side effects can in turn effect a patient’s perception of their procedures success. CH is the most 
frequent ETS complication and the most feared due to its drastic effect on patient satisfaction 
scores.1,6 CH normally occurs in the first 8 weeks to 1 year postoperative, can range from mild to 
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severe enough to effect activities of daily living(ADLs), can effect multiple body regions such as 
the face, axillae, trunk, abdomen, back, groin, lower limbs, and feet, and is so significant that it 
has been named the “quality marker of ETS.”1,2,6 
 Some limitations of this review or the studies it assess include small sample size, sample 
population, study length, classification definitions, and geographical location. PH occurs most 
often in young healthy patients, which can be problematic due to this populations tendency to 
migrate and thus not follow up with studies.6 Longer study length is shown to be more effective 
in capturing true patient outcomes that may not appear in the initial time frame, but may - No 
study had standardized terminology for CH, CH severity, or patient satisfaction. Yazbek et al1 
study classified CH as a place of diaphoresis on the body that was not present to surgery but 
didn’t distinguish if this includes only constant sweating or exclude any due to heat or exercise. 
In comparison, Ong et al6 modified an international society scale to define hyperhidrosis and 
labeled the most severe CH category as symptoms effecting ADLs.6 The other two studies 
arbitrarily granted patient preference for CH symptom severity.1,2 All studies focused on 
different body areas for CH occurrence: Yazbek et al.1 focused on the feet, legs, back, abdomen, 
and gluteal region; Turkyilmaz et al.2 focused on the back, waist, groin, and legs; Ong et al.6 
focused on the trunk, axillae, face and groin. Patient satisfaction was also not standardized 
between questionnaires, which varied from study to study. It was unclear if dissatisfaction 
included embarrassment, different diaphoresis thresholds such as being visible to others or if 
frequent changing of clothing was needed. It is theorized that climate could effect CH rates, such 
as those from the Yazbek et al. study1 located in Brazil and the Ong et al.6 study located in 
Singapore. Areas with higher year-round temperatures may lead to more sweating in general and 
thus falsely elevate CH incidences.1,6  
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CONCLUSION 
 The results from this systemic review suggest an endoscopic thoracic sympathectomy 
(ETS) at the T2 level is adequately effective in resolving palmar hyperhidrosis and resulting in 
patient satisfaction. All patients in the studies except one showed immediate anhidrosis 
postoperatively and no PH recurrence.1,2,6 Longer studies in the future would be even better at 
observing is if PH recurrence is a possibility. Despite great initial results, many patients 
developed undesirable CH symptoms without much improvement overtime. Despite high rates of 
CH in the Yazbek et al.1 and Ong et al.6 studies, the overall patient satisfaction rate was high in 
all three articles reviewed. Future research, on the subject of PH, would benefit and better 
represent truer patient outcomes and satisfaction levels if gathered over a longer time period, 
from a larger population, and/or in a less tropical study location climate. Standardizing 
definitions used in all studies on PH would help to improve the significance of their results and 
comparisons between similar research. Also, more tangible test results from sweat tests may help 




1. Yazbek G, Wolosker N, Kauffman P, Campos JR, Puech-Leao P, Jatene FB. Twenty 
months of evolution following sympathectomy on patients with palmar hyperhidrosis: 
Sympathectomy at the T3 level is better than at the T2 level. Clinics (Sao Paulo). 
2009;64(8):743-749. doi: 10.1590/S1807-59322009000800006 [doi]. 
 
2. Turkyilmaz A, Karapolat S, Seyis KN, Tekinbas C. Comparison of T2 and T3 
sympathectomy for compensatory sweating on palmar hyperhidrosis. Medicine 
(Baltimore). 2017;96(16):e6697. doi: 10.1097/MD.0000000000006697 [doi]. 
 
3. User S. Sweaty Hands - International hyperhidrosis society: Official Site. International 
Hyperhidrosis Society | Official Site. https://www.sweathelp.org/where-do-you-
sweat/sweaty-hands.html. Updated November 19, 2019. Accessed October 1, 2019. 
 
4. Crissman K. Cost of hyperhidrosis treatments and insurance coverage: My Carpe. Carpe 
Lotion. https://www.mycarpe.com/the-cost-of-hyperhidrosis. Published September 2, 
2018. Accessed October 1, 2019. 
 
5. American Academy of Dermatology. Hyperhidrosis | American Academy of 
Dermatology. https://www.aad.org/public/diseases/dry-sweaty-skin/hyperhidrosis#tips. 
Accessed October 1, 2019. 
 
6. Ong W, Lee A, Tan W, Lomanto D. Long-term results of a randomized controlled trial of 
T2 versus T2–T3 ablation in endoscopic thoracic sympathectomy for palmar 
hyperhidrosis. Surg Endosc. 2016;30(3):1219-1225. 
https://www.ncbi.nlm.nih.gov/pubmed/26150222. doi: 10.1007/s00464-015-4335-2. 
 
